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ABSTRACT
Clinical trials are essential for drug development but often suffer
from expensive, inaccurate and insufficient patient recruitment. The
core problem of patient-trial matching is to find qualified patients
for a trial, where patient information is stored in electronic health
records (EHR) while trial eligibility criteria (EC) are described in
text documents available on the web. How to represent longitudinal
patient EHR? How to extract complex logical rules from EC? Most
existing works rely on manual rule-based extraction, which is time
consuming and inflexible for complex inference. To address these
challenges, we proposed DeepEnroll, a cross-modal inference
learning model to jointly encode enrollment criteria (text) and pa-
tients records (tabular data) into a shared latent space for matching
inference. DeepEnroll applies a pre-trained Bidirectional En-
coder Representations from Transformers(BERT) model to encode
clinical trial information into sentence embedding. And uses a hier-
archical embedding model to represent patient longitudinal EHR. In
addition, DeepEnroll is augmented by a numerical information
embedding and entailment module to reason over numerical infor-
mation in both EC and EHR. These encoders are trained jointly to
optimize patient-trial matching score. We evaluated DeepEnroll
on the trial-patient matching task with demonstrated on real world
datasets. DeepEnroll outperformed the best baseline by up to
12.4% in average F1.
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1 INTRODUCTION
Clinical trial enrollment is a long-standing problem for drug de-
velopment. Often insufficient patients enroll in trials despite that
many of them having the target condition. The first barrier to trial
Permission to make digital or hard copies of all or part of this work for personal or
classroom use is granted without fee provided that copies are not made or distributed
for profit or commercial advantage and that copies bear this notice and the full citation
on the first page. Copyrights for components of this work owned by others than ACM
must be honored. Abstracting with credit is permitted. To copy otherwise, or republish,
to post on servers or to redistribute to lists, requires prior specific permission and/or a
fee. Request permissions from permissions@acm.org.
Conference’17, Washington, DC, USA
© 2016 ACM. 978-x-xxxx-xxxx-x/YY/MM. . . $15.00
DOI: 10.1145/nnnnnnn.nnnnnnn
participation is simple: many patients are unaware clinical trials are
open and relevant for them. Luckily, the availability of trial eligibil-
ity criteria (EC) online and the rich collection of patient electronic
health records (EHRs) data in hospitals bring a new promise to data
driven automated trial enrollment.
Over the years, both rule-based systems and machine learning
approaches were proposed for patient-trial matching. The rule-based
systems [16, 35] highly rely on laborious rule-setting and human
annotations. Also they yield poor recall due to the existence of
morphological variants and inadequate rule coverage. The machine
learning based models perform rule extraction automatically. For
example, Alicante et al., [1] applied unsupervised clustering meth-
ods for eligible rule extraction. Bustos et al., [6] evaluated several
classifiers including convolutional neural networks for EC classifica-
tion in cancer domain. Criteria2Query [36] utilized rules extracted
from [16] to generate matching patient definition. Despite their im-
provement over rule-based systems, existing patient-trial matching
methods still face the following challenges.
(1) Heterogeneous data from EC and patient EHR. Existing
methods take two steps to extract rules from EC first, which
could yield criteria that are too strict to find enough patients from
EHR data. However, simultaneous matching of EC and EHR is
difficult. ECs use unstructured natural language to describe eli-
gibility criteria. EHR, on the other hand, use structured clinical
codes to represent hospital visits of patients. There is a lack of
cross-modal representation that can link matched concepts in
ECs and EHR.
(2) Lack of explicit modeling for numerical information. EC
statements often include many numerical information such as
age, values of lab results and medication dosage. It creates
challenges for matching since numbers are a common source
of contradictions in natural language processing tasks [9], and
are also insensitive in distributed representations [26]. Existing
patient-trial matching works pay little attention to this issue.
To fill the gap, we proposed DeepEnroll to perform patient-
trial matching based on clinical trial EC and patient health data.
DeepEnroll is enabled by the following technical contributions.
(1) Joint embedding and entailment prediction to match het-
erogeneous data. DeepEnroll applies a Bidirectional En-
coder Representations from Transformers (BERT [10]) model
to encode clinical trial information. It also performs hierarchical
embedding to encode patient health data. And the patient-trial
matching are casted as an entailment prediction problem, where
we model patient embedding as hypothesis and trial embedding
as premise, and the objective is to predict whether a particu-
lar patient can be inferred from a given trial embedding. The
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encoders for EC and EHR and the entailment task are jointly
optimized to find good matches between trials and patients.
(2) Numerical information entailment module to explicitly match
numerical information. DeepEnroll is augmented by a nu-
merical information embedding and entailment module to explic-
itly reason over numbers. It proposes a numerical representation
to specifically encode numbers in textual input (EC). Then a
pattern-based comparison algorithm is developed for (1) ex-
tracting numbers from free-text ECs and (2) inference between
extracted numerical information in EC and EHR. Then the com-
parison results will be used to update the matching results.
We evaluated DeepEnroll on both real world clinical trial dataset
and a synthetic data. We evaluated the patient-trial matching via
predicting patient enrollment for trials. DeepEnroll outperformed
the best state-of-the-art baselines by up to 12.4% in average F1 and
6.8% in PR-AUC.
2 RELATED WORK
Patient-Trial Matching includes both rule-based and machine learn-
ing based models. Among rule-based models, EliXR [35] matches
Unified Medical Language System (UMLS) concepts and relations
via pre-defined dictionary and regular expressions. Another system
called EliIE [16] parses and formalizes free-text EC with OMOP
standard 1. The rule-based models learn to structuralize named enti-
ties and relations for clinical trials only, rather than for patient-trial
matching. In addition, they highly rely on rule-setting and human
annotations. Also they yield poor recall due to the existence of mor-
phological variants of ECs and inadequate rule coverage. As for
machine learning based algorithms, [1] that applies unsupervised
clustering methods for eligible rule extraction. Also [6] compared
CNN, SVM, and kNN as classifiers for EC classification in cancer
domain. More recently, Criteria2Query [36] is a hybrid information
extraction pipeline that combines machine learning and rule-based
methods to form patient criteria. Compared to the existing works,
DeepEnroll is an end-to-end deep learning model that achieves
significantly better performance as shown in the experiment.
Pre-training Techniques. The goal of pre-training techniques is to
provide model training with good initializations. Recently, language
model pre-training techniques such as [10, 23, 24] have shown to
largely improve the performance on multiple natural language pro-
cessing tasks. As the most widely used one, BERT [10] builds on the
Transformer [30] architecture and improves the pre-training using a
masked language model for bidirectional representation. Previously,
BERT has been applied on EHR data to leverage unlabeled data
for medication recommendation [27]. In this paper, we adapt the
framework of BERT and pre-train our clinical trial EC embedding
using large medical corpora.
Cross-modal Matching is enabled by joint embedding learning and
pairwise similarity learning. Joint embedding learning aims to find a
joint latent space where embedding of similar text and tabular data
are close [17, 32]. Pairwise similarity learning focuses on similarity
computation for the matching [15, 31]. For patient-trial matching
task, one EC statement could entail a group of EHR and vice versa.
1https://www.ohdsi.org/data-standardization/the-common-data-model/
Therefore, similarity learning is not appropriate due to the need for
capturing the many-to-many relationship.
3 METHOD
3.1 Problem Formulation
Patient EHR data for patient n can be represented as a sequence
of hospital visits H (n) = [h(n)1 · · ·h
(n)
N ]. Each hospital visit h
(n)
i
consists of a major diagnosis code d(n)i ∈ Vd and a set of asso-
ciated treatments(medications or procedures) M(n).Similarly, each
M(n)i consists of varying number of treatmentsm
(n)
i,1 , · · · ,m
(n)
i, |M (n)i |
.
The corresponding clinical trial m can be represented as E(m) =
(e(m)1 , · · ·e
(m)
M )where each e
(m)
i indicates the i-th EC and can be rep-
resented as a sequence of words: e(m)i = [a
(m)
i,1 ,a
(m)
i,2 , . . .]where a
(m)
i, j
is the j-th word in EC e(m)i . In this paper, we embed EC and EHR into
a shared latent space, whereU ∈ RM×o and V ∈ RN×o are the sets
of distributed representation of {e(m)1 , · · ·e
(m)
M } and {h(n)1 , · · ·h
(n)
N }
after transformation. The matching is casted as a multiclass classifi-
cation problem, where the matching results between {e(m)1 , · · ·e
(m)
M }
and {h(n)1 , · · ·h(n)N } are classified into the following categories: ”en-
tailment”, ”contradiction” and ”neutral”.
Table 1: Notations used in this paper.
Notation Description
E(m); V (n) EC set of the m-th trial; EHR set of the n-th patient
e(n)i the i-th EC of the n-th trial
Wd unnormalized attention weight matrix in alignment module
U ∈ RM×o ; V ∈ RN×o EC embedding set; EHR embedding set
v
(n)
i ;d
(n)
i ;M
(n)
i the i-th visit; major diagnosis; treatment codes of patient n
m(n)i, j the j-th treatment code from M
(n)
i
Ud ;Um weight matrix for predicting d
(n)
i andm
(n)
i, j
Wm ;Wo ;Wp1;Wp2 weight matrix for MLP layer
P set of demographics of given patient
pk the k-th demographics of given patient
oi visit-level embedding ofvi
u;v EC embedding; EHR embedding
α ; β soft-algined phrases ofv to u; of u tov
r1,r2 partly inference output from (u, β) and (v, α )
m aggregation output from r1 and r2
f ;д;h;r function for EHR hierarchical embeddings
σ non-linear activation function
M; N # of EC statements; # of EHR visits
y,y′ real, predicted outcome
3.2 The DeepEnroll Model
As illustrated in Fig. 1, DeepEnroll includes the following com-
ponents: a trial EC embedding module, a hierarchical patient repre-
sentation module, the alignment and entailment prediction module
that perform patient-trial matching via attentive comparison for soft-
aligned fragments. Next we will first introduce these modules and
then provide details of training and inference.
Trial EC Sentence Embedding Using BERT Clinical trial ECs are
in the form of unstructured text. To embed these data into meaningful
vector representations, we use a pre-trained BERT model as the base
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Figure 1: The DeepEnroll framework. DeepEnroll applies a pre-trained BERT model to encode clinical trial information into
sentence embedding U . And the hierarchical embedding model encodes patient health data into embedding V . Then the distributed
representationU andV are soft-aligned to capture the interaction from each side. In addition, DeepEnroll is augmented by a numer-
ical information embedding and entailment module to explicitly match numerical information representations (NIR) and reason over
numerical information in EC and EHR. At last, the match module predicts the matching scores from the interaction representations
r1 and r2. The results will be further updated by the result of numerical information entailment.
model for word and sentence representations. Based on a multi-
layer Transformer encoder [30], BERT is pre-trained using two
unsupervised tasks.
(1) Masked Language Model. Instead of predicting words based on
previous words, BERT predicts randomly masked words in a
sequence to learn better bidirectional representations.
(2) Next Sentence Prediction. In order to gain better sentence em-
bedding results which is used in our further matching prediction
task, BERT has a binary sentence prediction task to predict
whether one sentence is the next sentence of the other.
In particular, we applied the Clinical BERT [2], which was pre-
trained on three medical corpora including PubMed abstracts, PubMed
full-text articles, and MIMIC-III doctor notes. Then, we collect text
data for clinical trials, including trial condition, summary, descrip-
tion and ECs to further fine-tune the Clinical BERT. Last, we use
the fine-tuned BERT model to generate the EC sentence embedding
for downstream patient-trial matching tasks.
The trial EC embedding process can be formally described below.
We denote the fine-tuned BERT model as d(·) and the ECs of the clin-
ical trialn as E(n) = (e(n)1 , · · ·e
(n)
M ), where each e
(n)
i indicates the i-th
EC and is represented as a sequence of words: e(n)i = (a
(n)
i,1 , · · ·a
(n)
i,m ).
The embedding for each sentence is described as follow:
u(n)i = d(e
(n)
i ) = d(a
(n)
i,1 , · · ·a
(n)
i,m ) (1)
U (n) = {u(n)1 , · · ·u
(n)
M } (2)
where u(n)i represents the sentence embedding of the i-th EC state-
ment of clinical trial n and U (n) is the sequence of embedding for
the entire clinical trial i.
Hierarchical Patient Data Embedding Inspired by the multilevel
patient embedding strategy in [7], we also leverage the inherent
multilevel structure of EHR data to learn patient embedding. The
hierarchical structure of EHR data is structured as patient-level, visit-
level, then diagnosis codes and corresponding treatment codes for
that visit. Demographics information is also provided in patient-level,
including birth year, gender, country, geo location, ethnicity, and
blood type. We encode these medical codes and demographics as
using one-hot vectors. We first embedded into a dense representation,
and then apply a hierarchical network to learn patient embedding.
Formally, for each patient, we denote patient demographics as
pk ∈ P . Each visit hi encompasses treatments mi, j ∈ Mi and
diagnosis di . The hierarchical embedding process is given below.
д(di ,mi, j ) = σ (Wmr (di ))  r (mi, j ) (3)
f (di ,Mi ) = vi = σ (Wo (r (di ) +
|Mi |∑
j
д(di ,mi, j ))) (4)
h({p}, {v}) = σ (
| {p } |∑
k
Wp1r (pk ) +
| {v } |∑
i
Wp2vi ) (5)
We denote r (·) as a single MLP that encodes demographics
data pk , diagnosis codes di , and treatment codes mi, j into a z-
dimensional embedding. And a weighted matrixWm ∈ Rz×z con-
verts r (di ) into a different latent space to effectively capture its
interaction with r (mi, j ). The function f takes the distributed rep-
resentation of diagnosis code r (di ) and the sum of drug-treatment
interactions to become the visit-level embedding. Then, the function
h will integrate demographics embedding and visit embedding into
the patient-level embedding.
To fine-tune the patient embedding, we further develop an auxil-
iary prediction task to predict diagnosis code di and corresponding
treatment codesmi, j based on visit-level embedding oi .
di = p(di |oi ) = so f tmax(Udoi ) (6)
mi, j = p(mi, j |oi ) = σ (Umoi ) (7)
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WhereUd andUm are weight matrix to compute the prediction of
diagnosis code di and treatment codesmi, j respectively.
Alignment Module Attentive neural networks have demonstrated
success in entailment prediction tasks [20, 25]. In our case, we
regard the trial EC embedding as premise and the encoded EHR as
hypothesis. Our task is to predict whether the hypothesis is entailed
in the premise, i.e. given a trial EC, whether a particular patient is a
match for the trial.
First, we create a soft-alignment matrix using neural attention be-
tween a set of premises and hypotheses. Next, we use the alignment
vectors to decompose our task into two sub-problems.
(1) Given a certain premise, predict the entailment between the
premise and all hypothesises.
(2) Given a certain hypothesis, predict the entailment between the
hypothesis and all premises.
Such a decomposition allows every EC to be soft-aligned to all
related EHR, as well as every EHR to all related EC. Accordingly,
the match module can capture the entailment relations between all
EC and EHR pairs.
Formally, we denoteU = {u1, · · · ,uM } as a set of premises and
V = {v1, · · · ,vN } as a set of hypothesises, where ui ,vj ∈ Ro . We
feed elements from premise and hypothesis into a shared transfor-
mation layer parameterized by (Wc ,bc ) and obtain unnormalized
attention weights as soft-alignment matrixWd .
W (i, j)d = σ (Wcui + bc )T σ (Wcvj + bc ). (8)
Here σ is an activation function (e.g., ReLU in our case) that oper-
ates element-wise over a vector. AndW (i, j)d is the attention weight
between ui andvj . The soft-alignment matrix is then used to obtain
the weighted summation for premise as βi and hypothesis as α j .
βi =
∑
j=1
exp(W (i, j)d )∑
k=1 exp(W (k, j)d )
vj , (9)
α j =
∑
i=1
exp(W (i, j)d )∑
k=1 exp(W (k, j)d )
ui (10)
Here βi is the related hypothesis in V that is softly aligned to ui ,
while α is the related premise in ECU that is softly aligned to vj .
And {βi } is formal representation for the input of sub-problems (1).
{α j } is formal representation for the input of sub-problems (2).
The proposed decomposable soft-alignment has two major ben-
efits. First, the aligned vectors focus on only related local sub-
structure, which is proved to be effective for entailment inference
task [20]. Second, the decomposition avoids the quadratic complex-
ity (M×N times) and only requires linear complexity (M+N times).
Match via Entailment Prediction Given the output from the align-
ment module, we jointly consider interactions between single EHR
and EC as well as for the original EC embeddings and EHR em-
beddings (vj ,α j ) and (ui , βi ) by feeding their concatenation into a
shared transformation layer to compute the entailment relationship
between given patient and trial.
r1,i = σ (Wa [(ui , βi )] + ba ) (11)
r2, j = σ (Wa [(vj ,α j )] + ba ) (12)
Where (Wa ,ba ) are the parameters for the transformation layer. The
output r1,i and r2, j represent the entailment prediction results for
sub-problems (1) and sub-problems (2), respectively. They are used
to aggregate into the final entailment inference results.
r1 =
∑
i=1
r1,i , r2 =
∑
j=1
r2, j (13)
Where r1 and r2 are the summation of the prediction results of the
two sub-problems. Following the aggregation method from [19],
we adapt three aggregation methods: (a) vector concatenation;(b)
element-wise product; (c) element-wise difference, to measure their
similarity and closeness in latent space. The aggregated representa-
tions are then feed into a final output layer.
m = [r1,r2,r1 · r2,r1 − r2] (14)
y′ = p(y |m) = somax(Wfm + bf ) (15)
where (Wf ,bf ) are the parameters for output layer. y′ represents the
predicted label, including ”entailment”, ”contradiction”, and ”neu-
tral”. The entire embedding and entailment prediction process is
summarized in Algorithm 1.
Numerical Information Entailment Numerical information in ECs
such as age or dosage is important for patient-trial matching. How-
ever, it is difficult to match them since numbers are a common source
of contradictions in natural language processing tasks [9], and are
often insensitive in distributed representations [26]. To explicitly
model these numerical information, we proposed the following nu-
merical information representation(NIR).
The design of NIR is inspired by [12, 26]. We first encode nu-
merical information as a triplet (q,u, c), where the three variables
correspond to number, unit, and concept, respectively.
• Number q: The lower or upper bound for a value range. e.g. more
than 500 mg, at least one month, during last three months. We do
not store the surface forms but convert them into a set of ranges.
For example, ”more than 20 mg” is stored as (20,+∞).
• Unit u: is about the scale a value is measured. e.g., mg, weeks.
The word ”weeks” in the phrase ”within 12 weeks” is a unit.
• Concept c: an aligned concept that the quantity is associated with.
e.g. certain drug or procedure. This is stored for augmentation of
quantity and input representations.
Next, we develop the following method. Given a sequence of
tokens {xi }, we extract its word-level features and character-level
features to recognize numerical information. In word-level, we can
recognize if xi appears in a set of known scientific units(e.g., mcg,
g/L), written numbers. In character-level, xi can contain a digit, have
all digits, or include a suffix (st,nd,rd,th). Then the extraction results
are formulated as the numerical information representation with
standardization including numbers converting into floating points
and fixed date type, and units converting into standard base unit.
Finally, we design a numerical information comparison method to
infer the entailment between NIR learned from ECs and numerical
information in EHR. Numerical information in EHR are often repre-
sented as a fixed value with unit. Therefore, we firstly check whether
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two units are comparable. If comparable, we would then compare
the fixed value with the value range in NIR. The entailment results
would includes: ”entailment”, ”contradiction” and ”not comparable”.
Only the ”entailment” ones should be regarded as supported by the
numerical information entailment module.
Algorithm 1 DeepEnroll for Patient-Trial Matching
Input: A set of labelled triplet {E(i),H (i),yi }i=Ni=1 . Let N equals
the size of training set.
1: for iter = 1 . . . N do
2: U (i)← EC Sentence Embedding(E(i))
3: V (i)← Hierarchical Patient Embedding(H (i))
4: {βj },{αk } ← Concept Alignment(U (i),V (i))
5: if Entailment Match({βj },{αk }) = Entailment then
6: if Quantity Match(E(i),H (i)) = Entailment then
7: return Entailment
8: else
9: return Contradiction
10: end if
11: else if Entailment Match ({βj },{αk }) = Contradiction then
12: return Contradiction
13: else if Entailment Match ({βj },{αk }) = Neutral then
14: return Neutral
15: end if
16: end for
Output: Trained deep embedding and entailment prediction model.
4 EXPERIMENT
We evaluated DeepEnroll model on three datasets, including
two sets of proprietary matched trial and EHR data, and a publicly
available synthetic data. The code can be found in 2 We designed
experiments to answer the following questions.
Q1: Does DeepEnroll have better performance in matching pa-
tients and trials as measured by predicting clinical trial enrollment?
Q2: Does the numerical information entailment module help im-
prove the performance of DeepEnroll?
Q3: Can DeepEnroll provide interpretable matching results?
4.1 Experimental Setting
Data The data used in experiments are listed below.
• Clinical Trial EC We randomly selected 794 clinical trials with
varying disease domains from ClinicalTrials.gov. Firstly we down-
loaded the XML files for the clinical trials. Each file follows a
fixed structure defined by the clinical trial XML schema. We se-
lect the Inclusive Criteria and Exclusive Criteria to form raw ECs.
Then we extract EC statements from the free-text raw ECs through
patter-based paragraph segmentation and sentence segmentation.
In total, we obtain 12,445 sentence-level EC statements for 794
clinical trials.
• Large Scale Patient-Trial Matching Data (IQVIA dataset) We
use this trial-patient matched data for model training and valida-
tion, noted as IQVIA dataset. It contains 561 registered clinical
trials and 57,696 matched patients. The patient information is
2https://github.com/deepenroll/DeepEnroll
encoded in a large-scale longitudinal prescription and medical
claims data. For each trial, a number of free-text EC statements
describe trial requirements from different aspects. Patients are
profiled as a set of EHR, including records of diagnosis, and
treatments. We define the inclusive EC and exclusive EC and
their corresponding matched patients’ EHR as one ”Entailment”
or ”Contradiction”. As to unmatched EHR and EC statements,
we labelled them as ”Neutral”. In all we have 852,1031 labelled
examples.
• Rare Disease Data. The rare disease data is a subset of IQVIA
dataset, which contains conditions from the rare diseases list
provided by the national organization for rare disorders(NORD).
This results in 77 trials and 562 matched patients from IQVIA
dataset.
• Synthetic Data For reproducibility, we also develop a synthetic
data based on [36] using Synthea 3, a synthetic patient popula-
tion simulator to automatically generate patient EHR. We select
243 registered trials from a wide range of disease domains, and
leverage Criteria2Query to generate cohort definitions for filter-
ing matched patient EHRs. In total, we have 68,845 simulation
EHRs, which is labelled in similar way as IQVIA dataset. Details
for synthetic data generation can be found in Section 7 of the
appendix.
Table 2: Data Statistics
Statistic IQVIA Synthetic Rare Disease
# of trials 561 243 77
# of EC statements 9,510 2,935 1,394
Avg. EC sentence length 24.2 21.3 23.4
# of patients 57,696 13,634 562
# of EHR 852,103 68,845 9,580
# of unique medications 352 156 294
# of unique diagnosis 939 288 309
Baseline We compared DeepEnroll with the following baselines.
• Logistic Regression (LR) [14] We concatenate sentence embed-
ding of EC and one-hot EHR vectors and apply LR to make
multiclass classification.
• Multi-Layer Perception (MLP) is leveraged as entailment infer-
ence module [4, 8]. The model is simply a stack of three 200d
tanh layers, with the bottom layer taking the concatenated premise
and hypothesis word representations as input and the top layer
feeding a softmax classifier.
• Long Short Term Memory (LSTM) [13]. We apply two LSTM
to model both premise sequence and hypothesis sequence and
then use the corresponding final output for entailment prediction.
• match-LSTM (mLSTM) [33] perform word-by-word matching
of the hypothesis with the premise.
• Stack Augmented Parser Interpreter Network (SPINN) [5]
combines parsing and interpretation within a tree-sequence hybrid
model by integrating tree structured sentence interpretation.
• Word-by-word Attention(WA) [25] is an entailment inference
model that utilize the output latent state of premise LSTM as
3https://github.com/synthetichealth/synthea
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the input of hypothesis LSTM. Then a word-by-word attention is
developed for both LSTM for entailment prediction.
• Criteria2Query [36] is the current state-of-the-art work for patient-
trial matching task. It implements a systematic information extrac-
tion pipeline to parse free-text eligibility criteria into a structured
and computable representation using the OMOP CDM, and also
leverages a series of natural language inference techniques such as
named entity recognition to autonomously generate matching pa-
tient definition to identify patient cohorts Note that we would not
compare its performance on Synthea dataset, which is generated
through Criteria2Query.
Metrics To measure the accuracy of matching, we use the average F1
and Precision Recall AUC (PR-AUC) as our metrics. Precision, Re-
call, and F1 score are computed on the number of true positives (TP),
false positives (FP), and false negatives (FN). PR-AUC measures
the area under the precision-recall curve. F1 score is the harmonic
mean of precision and recall. Since the entailment prediction task is
casted as a multi-label classification task, we consider micro-F1 as
the metric and calculate average F1 based on that.
Evaluation Strategy All methods are implemented in PyTorch [21]
and trained on an Ubuntu 16.04 with 64GB memory and three GTX
1080 Ti GPU. For all datasets, we randomly select 60% of the pa-
tients as training set, 20% as validation set and the remaining 20%
as test set. We train the model using training data, and fix model
parameters based on the best model performance on validation set.
We then test the model on test set. We perform three random runs
and report both mean and standard deviation for testing performance.
Implementation Details. We use stochastic gradient descent (SGD)
with a learning rate of 0.1 and a weight decay of 0.99. At each
epoch, we divide the learning rate by 5 if the dev accuracy decreases.
We use mini-batches of size 64 and training is stopped when the
learning rate goes under the threshold of 10e-5. For the classifier,
we use a multi-layer perception with 1 hidden-layer of 512 hidden
units. We use dropout [29] with a rate of 0.5, which is applied to
all feedforward connections. For the pre-trained Clinical BERT, We
use a batch size of 32 and fine-tune for 3 epochs over the data for
two unsupervised task. For each task, we selected the fine-tuning
learning rate of 2e-5.
For all baselines except for Criteria2Query, we use 300 dimen-
sional GloVe embedding [22] as word embedding and max-pooling
as sentence embedding method. Out-of-vocabulary (OOV) words
are hashed to one of 100 random embedding each initialized to
mean 0 and standard deviation 1. All other hidden layer weights
were initialized from random Gaussian distribution with mean 0
and standard deviation 0.01. Each hyperparameter setting was run
on a same machine as the DeepEnroll, using Adagrad [11] for
optimization with initial accumulator value of 0.1. For EHR data, we
convert them into one-hot vectors as the hypothesis representation.
As for Criteria2Query, we directly use the existing model to produce
the matching results for given trials and patients.
Q1: DeepEnroll achieved the best predictive
performance in clinical trial enrollment prediction
We compared DeepEnroll against the state-of-the-art baselines
on IQVIA dataset, the synthetic data, and the rare disease data. We
reported the results in Table. 3, Table 4 and Table 5, respectively.
The best results are presented in bold figures.
Table 3: Performance Comparison on IQVIA dataset.
Model Average F1 PR-AUC
LR 0.5675± 0.0003 0.6580± 0.0005
MLP 0.5864± 0.0001 0.6738± 0.0000
LSTM 0.6225±0.0001 0.6871±0.0001
SPINN 0.6331±0.0042 0.7014±0.0063
Word-by-word Attention 0.6457±0.0012 0.7163±0.0021
match-LSTM 0.6641±0.0007 0.7423±0.0011
Criteria2Query 0.6819±0.0001 0.7103±0.0002
DeepEnroll 0.7543±0.0018 0.7864±0.0083
Table 4: Performance Comparison on synthetic data. C2Q is not
compared here since it was used in data synthesis.
Model Average F1 PR-AUC
LR 0.6123±0.0002 0.6849±0.0003
MLP 0.6231±0.0001 0.6914±0.0000
LSTM 0.6424±0.0002 0.7092±0.0003
SPINN 0.6233±0.0074 0.6712±0.0078
Word-by-word Attention 0.6245±0.0019 0.6821±0.0034
match-LSTM 0.6542±0.0013 0.6956±0.0025
DeepEnroll 0.7298±0.0013 0.7431±0.0029
Table 5: Performance comparison on rare disease data.
Model Average F1 PR-AUC
LR 0.5518± 0.0004 0.6375± 0.0012
MLP 0.5454± 0.0001 0.6844± 0.0000
LSTM 0.6163±0.0002 0.6782±0.0002
SPINN 0.6194±0.0061 0.6892±0.0078
Word-by-word Attention 0.6357±0.0014 0.7065±0.0023
match-LSTM 0.6442±0.0009 0.7133±0.0021
Criteria2Query 0.6155±0.0001 0.6481±0.0001
DeepEnroll 0.7241±0.0011 0.7453±0.0029
From the results, we observe that DeepEnroll consistently
achieves the best performance against best baselines. On IQVIA
dataset, it outperformed the best baseline Criteria2Query by 10.6%
in Average F1 and match-LSTM by 5.9% in PR-AUC. On the syn-
thetic data, it outperformed the best baseline match-LSTM by 11.5%
in Average F1 and 6.8% in PR-AUC. On rare disease dataset, it
outperformed the best baseline match-LSTM by 12.4% in Average
F1 and 4.5% in PR-AUC.
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Among the baselines, LR and MLP have the worst performance
due to they fail to capture the temporal patterns in EC text and patient
data, thus cause the inferior matching performance. Compared with
them, the LSTM and the word-by-word attention model manage
to capture long-range temporal dependencies among both EC and
patient data. The SPINN model uses a tree-sequence hybrid structure
for better sequence modeling. Thus they demomnstrated improved
performance over LR and MLP.
The two best baselines are match-LSTM and Criteria2Query. The
match-LSTM model is a LSTM-based natural language inference
model. It performs word-by-word matching of the hypothesis with
the premise, such that it not only can place more emphasis on impor-
tant word-level matching results, but also can remember important
mismatches that are critical for predicting the contradiction or the
neutral relationship label. With this design, match-LSTM has greatly
improved performance compared with the other LSTM-based mod-
els. On the other hand, Criteria2Query [36] implements a systematic
information extraction pipeline to parse free-text eligibility criteria
into a structured and computable representation using the OMOP
CDM, and also leverages a series of natural language inference tech-
niques such as named entity recognition to autonomously generate
matching patient definition to identify patient cohorts. It achieved
very good performances across all clinical trials due to rule extrac-
tion and natural language inference techniques. However, on rare
disease trial data, the performance of Criteria2Query is not encour-
aging, which could be due to the lack of full knowledge of rare
diseases in the knowledge system it builds on. One example was that
Criteria2Query showed confusing results in recognize numerical re-
strictions: Heart failure with ejection fraction ≤ 40 (NCT04078425).
Criteria2Query would recognize only Heart failure while DeepEnroll
could recognize the specific numeric criteria for matching.
To compare with retrieval-style baseline, we used solr[28] to
query 20 clinical trials with textual descriptions of EHR formatted
in bag of words, including demographics and name of diagnosis,
products, and procedures. The F-1 score for top 5 results is 0.4731
and for top 10 is 0.5378 (vs. DeepEnroll 0.7543). As to the baselines
mentioned in Related Work, the baseline Criteria2Query already
uses the same retrieval component as EliXR and EliIE.
In this experiment, we also evaluated model performance on
patient-trial matching for rare diseases. Recruiting suitable patients
to trials for rare diseases is challenging. This is because often there
are few patients with rare diseases. It may not be feasible to signif-
icantly narrow entry criteria based on disease stage or other char-
acteristics [3]. From the results in Table 5, we can observe that
although the performance of all models decreased, DeepEnroll
still output performed all baselines with a 7.99% improvement and
demonstrated a minimal performance reduction. Among baselines,
Criteria2Query has the biggest performance drop since it heavily
relies on disease guidelines, which are not sufficient for rare diseases.
Q2: The numerical information entailment module
augments the performance of DeepEnroll
We conduct an ablation study to understand the contribution of nu-
merical information representation and entailment module (NIR) in
DeepEnroll. We remove the NIR module in patient-trial match-
ing and perform trial enrollment prediction using the reduced model.
We compared the prediction results against the full model across all
datasets. The parameters in the reduced model are determined with
cross-validation, and the best performances are reported in Table 6.
Table 6: Abalation study of DeepEnroll demonstrated the ad-
vantage of numerical information entailment augmentation.
Dataset Metric w/o NIR DeepEnroll
IQVIA dataset
PR AUC 0.7611±0.0094 0.7864±0.0083
F1 Score 0.7392±0.0021 0.7543±0.0018
Rare Disease
PR AUC 0.7258±0.0032 0.7453±0.0029
F1 Score 0.7012±0.0011 0.7241±0.0011
Synthetic Data
PR AUC 0.7399±0.0028 0.7431±0.0029
F1 Score 0.7211±0.0013 0.7298±0.0013
From Table. 6, it is easy to see when we solely leverage the EC
sentence embedding and hierarchical patient embedding for entail-
ment match, the performances are largely reduced. For example,
on IQVIA dataset and rare disease data, the performance could
be decreased by up to 3.32% in PR-AUC and 3.26% in F1 score.
In conclusion, it suggests the necessity of augmenting textual rep-
resentation with explicit embedding and entailment for numerical
information in trial-patient matching task.
Q3: DeepEnroll can provide interpretable
matching results
To better facilitate clinical decision making, we also design the
following strategy to understand the key factors for matching patients
and trials. For each trial considered in case study, we randomly select
12 patients who are enrolled in the trial. We collect the soft-alignment
attention weights, and then visualize them using heatmaps.
Here, we select the following trials: trials on heart failure (HF,
NCT03882710), Alzheimer’s Disease (AD, NCT03690193) and idio-
pathic pulmonary fibrosis (IPF, NCT02085018). Each row represent
one EC statement and one column shows one patient embedding. We
chose 5-6 representative EC statements with relatively high attention
weights. We leveraged the weighted average of attention weights
between EHR and EC into patient level (β), and visualize the impact
of each EC statements on the selected patients. We utilize ECharts as
our visualization tool 4. Light color indicates lower relevance while
dark color means strong relevance.
Heart failure is a serious condition such that the heart of HF
patient cannot keep up with its workload. The body of the patient
may not get the oxygen it needs. HF has no cure. Drugs for HF
are designed to help patients better manage their conditions. From
Figure 2 (a), the most relevant EC statement requires the patients
to have no ”other systemic disease limiting life expectancy to less
than 3 years” mainly due to the the clinical trial will take more than
3 years. Another important statement is about ”LVEF ≥ 50% in a
nondilated LV”, which is a key sign of HF.
Alzheimer’s disease (AD) is an irreversible, progressive brain
disorder that slowly destroys memory and thinking skills, and, even-
tually, the ability to carry out the simplest tasks. Currently, there is
no cure for AD or a way to stop its progression. Drugs and treatments
4https://www.echartsjs.com
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Figure 2: Heatmap showing the attention weights for EC state-
ments and patient pairs. Rows represent EC statements (e.g.,
inclusion and exclusion) and columns are patient embedding.
Dark color indicates strong relevance. Matched patients of each
trial are highlighted.
are developed to either cure AD or help treat some symptoms of
AD. From Figure 2 (b), the most relevant EC statement states that in
order for the patients to be considered for the trial, their major organ
should have normal functions, and also patients with diabetes and
cancer should be excluded. For AD trial, BMI measure and behavior
description are less important.
The last example is for a trial on treating idiopathic pulmonary
fibrosis (IPF). IPF is a pulmonary disease that is characterized by the
formation of scar tissue within the lungs in the absence of any known
provocation [18]. IPF is a rare disease which affects approximately 5
million people worldwide, with prevalence rate at 0.04%. Currently
there is no cure for IPF. Treatments are being developed and tested
to slow the rate of scarring (pirfenidone and nintedanib) and treat
particular IPF symptoms such as breathlessness and coughing. From
Figure 2 (c), for this trial the most relevant EC statement states the
patients should have ”history of cough”, and have no ”known allergy
to Opeprazole or other proton pump inhibitor”.
Through visualization, we conclude that the attention weights in
DeepEnroll help better understand the key inclusion and exclu-
sion criteria for successful recruitment of patients.
4.2 Case Study: trials that are difficult to match
patients with machine learning models
Figure 3: Attention weights for BLITZ Heart Failure trial.
Matched patients are highlighted.
Among our experiments, for some clinical trials, it is not easy to
use machine learning models to match patients. To analyze the pos-
sible reason, we select a trial that has shown lower than 30% correct
patient-trial matching using either DeepEnroll or Criteria2Query.
The trial is named BLITZ Heart Failure (NCT03661060), which is
an observational study designed to evaluate whether a structured
educational program can improved the patient adherence from both
acute and chronic HF patients to guidelines recommendations.
We take a similar strategy to visualize its attention matrix in
Figure 3. There are two possible reasons for the low matching per-
formance. First, there are many over-simplified abbreviation in trial
EC statements, such as the ones shown in the forth and fifth rows.
The over-simplified description could be ambiguous and hard to
match with concepts in patient EHR. In addition, the EC statement
in the sixth row has relatively high attention weights, but is actually
unrelated to information from patient EHR.
5 CONCLUSION
In this paper, we proposed DeepEnroll, a cross-modal infer-
ence learning model to jointly encode enrollment criteria and pa-
tients records into a shared latent space for patient-trial matching.
DeepEnroll applies a pre-trained BERT model to encode clin-
ical trial information, and a hierarchical model to embed patient
EHR. DeepEnroll is also augmented by a numerical informa-
tion embedding and entailment module to explicitly match numer-
ical information in EC and EHR. We eva both real world clini-
cal trial dataset and a synthetic data. Experiments on real-world
datasets demonstrated the strong performance of DeepEnroll.
The DeepEnroll method can also be extended to other applica-
tion domains for matching problems based on heterogeneous data,
such as personalized targeted advertising that is based on match-
ing Ads description (in text) and customers’ browsing history (in
sequential data).
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7 APPENDIX: DETAILS ON GENERATING
THE SYNTHETIC DATASET
For model reproducibility, we generated a synthetic data following
the procedure below.
(1) Data Gathering. For clinical trial data, we downloaded 1,000
clinical trial descriptions from a https://clinicaltrials.gov. Each
trial is stored in an XML file that follows a structure of fields
defined by an XML schema. We select the EC items in free-text
format from XML files as our original dataset. Then, we split
EC into statements by considering different types of bullet and
lists symbols as the natural sentence splitting signs.
(2) EHR Generation. According to [34], EC items could be divided
into the following categories:demographic information; condi-
tion occurrence, procedure occurrence; measurement; drug ex-
posure; observation; and willing information. Except for willing
and demographic information, other categories can be mapped
with corresponding tables in EHR system. For each EC record,
we use the Criteria2Query [36] system to generate a correspond-
ing EHR query in CDM v5.0 format, which includes the cate-
gory label for EC and the EHR query information. Then, we run
these queries in ATLAS (github.com/OHDSI/Atlas), an online
EHR query engine to generate eligible patient-level EHR infor-
mation. These information are stored in relational database. We
developed a algorithm to translate the database information into
natural text.
(3) Labelling. Last, the matching EHR and EC are labelled as En-
tailment for inclusion criteria and Contradiction for exclusion
criteria. Additionally, a number of unrelated EHR and EC pairs
are also generated and labelled as Neutral. The labeling process
forms tuples in the form of (E,H ,y) as model input.
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